Sanara MedTech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sanara MedTech generated cash of -$3,245,556, which is more than the previous year. Cash used in financing activities reached the amount of $9,641,123 last year. Net change in cash is therefore -$3,811,779.
Cash Flow
| 2014 | -1.68M | -8.44K | 2.17M |
|---|---|---|---|
| 2015 | -1.20M | -5.33K | 867.12K |
| 2016 | 409.24K | -3.02K | 244.92K |
| 2017 | -139.86K | -85.87K | -144.55K |
| 2018 | 277.14K | -8.48K | -208.10K |
| 2019 | -2.16M | -1.19M | 9.80M |
| 2020 | -4.03M | -2.74M | 622.33K |
| 2021 | -4.81M | -5.28M | 28.29M |
| 2022 | -5.55M | -3.51M | -627.34K |
| 2023 | -3.24M | -10.20M | 9.64M |
SMTI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.95M | 18.65M | 455.36K | 6.61M | 176.42K | 463.18K | 833.48K | 182.33K | 523.44K | 44.55K |
Operating activities | ||||||||||
Net income | -4.30M | -8.09M | -7.99M | -4.44M | -2.83M | -600.57K | 331.30K | -415.74K | -1.34M | -2.27M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.67M | 2.37M | 596.97K | 291.37K | 119.95K | 83.89K | 80.64K | 60.88K | 60.03K | 56.44K |
Stock-based compensation expense | 3.44M | 2.70M | 2.66M | 1.40M | 0 | 0 | 60.25K | 813.94K | 44.58K | 534.08K |
| Deferred income tax benefit | 3.44M | 2.70M | 2.66M | 1.40M | 0 | 0 | 60.25K | 813.94K | 44.58K | 534.08K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.73M | -2.26M | -774.80K | -961.46K | -324.36K | 609.23K | -64.41K | -503.23K | 20.25K | -76.98K |
Inventories | -1.54M | -517.27K | -1.15M | -719.81K | -281.20K | 262.88K | -420.42K | -91.22K | -140.99K | -178.44K |
Accounts payable | 575.14K | -423.74K | 99.13K | 88.66K | -84.63K | -167.99K | -6.71K | 15.87K | 33.18K | 18.1K |
Cash generated by operating activities | -3.24M | -5.55M | -4.81M | -4.03M | -2.16M | 277.14K | -139.86K | 409.24K | -1.20M | -1.68M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -250K | -4.53M | -1.1M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -265.24K | -747.01K | -750.45K | -1.64M | -1.70M | -8.48K | -85.87K | -3.02K | -5.33K | -8.07K |
Acquisitions Net | -9.94M | -2.51M | 0 | 0 | 508.97K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -10.20M | -3.51M | -5.28M | -2.74M | -1.19M | -8.48K | -85.87K | -3.02K | -5.33K | -8.44K |
Financing activities | ||||||||||
Common Stock Issued | 911.37K | 0 | 28.93M | 11.36M | 10.00M | 15.00K | 50.05K | 0 | 750K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -32.49K | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -442.52K | 39.33K | -1.06K | 0 | 0 | 0 | 0 | -9.99K |
Repayments of term debt | 9.68M | 0 | -800K | -583K | 0 | 0 | -3.76K | -4.71K | 117.12K | -68.5K |
Cash used in financing activities | 9.64M | -627.34K | 28.29M | 622.33K | 9.80M | -208.10K | -144.55K | 244.92K | 867.12K | 2.17M |
Net Change In Cash | -3.81M | -9.69M | 18.19M | -6.15M | 6.43M | 268.66K | -370.29K | 651.14K | -341.10K | 478.88K |
Cash at end of period | 5.14M | 8.95M | 18.65M | 455.36K | 6.61M | 731.84K | 463.18K | 833.48K | 182.33K | 523.44K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |